Related references
Note: Only part of the references are listed.Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
Milim Kim et al.
BREAST CANCER RESEARCH (2020)
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer
Peiwen Ma et al.
FRONTIERS IN IMMUNOLOGY (2019)
Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer
Elham Safarzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives
Elahe Safari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci et al.
SEMINARS IN CANCER BIOLOGY (2018)
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Rebekka Weber et al.
FRONTIERS IN IMMUNOLOGY (2018)
Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients
Dujuan Wang et al.
FRONTIERS IN ONCOLOGY (2018)
Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status
Yul Ri Chung et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Mechanism of immune evasion in breast cancer
Mozhi Wang et al.
ONCOTARGETS AND THERAPY (2017)
Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment
Michel Eisenblaetter et al.
THERANOSTICS (2017)
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome
P. Miller et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Hornerin Is Involved in Breast Cancer Progression
Jinhyuk Choi et al.
JOURNAL OF BREAST CANCER (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
Chunwan Lu et al.
ONCOIMMUNOLOGY (2016)
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
Viktor Umansky et al.
VACCINES (2016)
S100A9 expressed in ER-PgR- breast cancers induces inflammatory cytokines and is associated with an impaired overall survival
Caroline Bergenfelz et al.
BRITISH JOURNAL OF CANCER (2015)
Correlation between myeloid-derived suppressor cells and S100A8/A9 in tumor and autoimmune diseases
Ruoting Zheng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
The role of inflammation in progression of breast cancer: Friend or foe?
Michael D. Allen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Jo Marie Tran Janco et al.
JOURNAL OF IMMUNOLOGY (2015)
Infiltrating S100A8+myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome
Katherine Drews-Elger et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors
Jyothi S. Prabhu et al.
JOURNAL OF CANCER (2014)
RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition
Chonggao Yin et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
Eva Schlecker et al.
JOURNAL OF IMMUNOLOGY (2012)
S100A8 and S100A9: New Insights into Their Roles in Malignancy
Geetha Srikrishna
JOURNAL OF INNATE IMMUNITY (2012)
Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells
Srinivas Nagaraj et al.
SEMINARS IN CANCER BIOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
Eric Tartour et al.
CANCER AND METASTASIS REVIEWS (2011)
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Ping-Ying Pan et al.
CANCER RESEARCH (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast
Kazumori Arai et al.
CURRENT CANCER DRUG TARGETS (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)